National Hospital Organization Nagoya Medical Center
2 clinical trials · Sponsor
◉ Watch National Hospital Organization Nagoya Medical Center
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 (NCT04396457) | National Hospital Organization Nagoya Medical Center | 2020-05-25 |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 (NCT03286634) | National Hospital Organization Nagoya Medical Center | 2017-04-18 |
Track National Hospital Organization Nagoya Medical Center automatically
Every clearance here is in the API, with alerts when new ones post.